The company is exhibiting its portfolio of synapse integrated solutions and spotlight enhanced features and next generation upgrades at the event, which is being held from 27 November to 2 December 2016 at McCormick Center in Chicago, Illinois. 

The products that will be showcased at the event include Synapse 5, Synapse VNA and Synapse RIS.

Synapse 5 is claimed to be the next generation, secured server-side technology which offers instant access to massive datasets.

Diagnostic breast tomosynthesis and MPR/Fusion remove the need for disparate workstations or separate applications to complete workflows. The system received clearance from the US Food and Drug Administratio in February this year.

Synapse VNA is an enterprise-wide medical information and image management solution that offers vendor-neutral, scalable storage and distribution system for digital imaging and communications in medicine (DICOM) and non-DICOM objects.

Fujifilm claims that it used its imaging domain experience in areas such as ultrasound, endoscopy, cardiology, radiology and digital imaging to offer an enterprise imaging suite.

Synapse RIS helps radiology facilities to command their operations. It is claimed to be a full-featured, workflow management system which is fully integrated with Synapse PACS.

It is equipped with an advanced Scheduling Intelligence Engine, patient portal, business intelligence analytics and has a flexible architecture with modern interoperability standards.

FUJIFILM Medical Systems USA Medical Informatics vice president Bill Lacy said: “Enterprise Imaging is rapidly evolving as a necessary organizational priority for health systems across the globe and Fujifilm’s Synapse portfolio is the most comprehensive solution available today.

“Our Synapse solutions provide core technology to allow health care organizations to deploy an Enterprise Imaging strategy that addresses modern IT architecture needs, security, cost saving operational efficiencies, physician needs, improved outcomes and diagnostic imaging excellence.”